Maria A. Blasco

Maria A. Blasco is a leading researcher at the Spanish National Cancer Research Centre (CNIO), where she has served as Head of the Telomeres and Telomerase Group since 2003. She previously directed the Molecular Oncology Program (2003-2011) and served as Vice-Director of Basic Research (2005-2011) at CNIO, establishing herself as a pivotal figure in Spanish cancer research.

Her academic foundation includes a BSc (1989) and PhD (1993) in Biochemistry and Molecular Biology from Autónoma University, Madrid, followed by postdoctoral training at Cold Spring Harbor Laboratory under Nobel laureate Dr. Carol W. Greider (1993-1996), where she specialized in telomere biology.

Dr. Blasco's research program centers on telomeres and telomerase, investigating their mechanistic roles in cancer initiation and aging processes. Her work bridges epigenetics, stem cell reprogramming (including induced pluripotent stem cells), and nuclear dynamics to explore longevity determinants and health span extension. This integrative approach has positioned her at the forefront of understanding how telomere dysfunction drives oncogenesis and age-related pathologies.

Her transformative contributions have earned international recognition through numerous prestigious awards:

• Körber European Science Award (2008)
• Rey Jaime I Prize for Basic Research (2007)
• Member of Academia Europaea (2006)
• Josef Steiner Cancer Research Award (2003)
• Universalia Research Award (2003)
• European Life Sciences Organization Early Career Award (2002)
• SEBBM Beckman/Coulter Award (2001)
• Swiss Bridge Award for Cancer Research (2000)
• Fellow of the Royal Academy of Pharmacy of Spain (2013)
• Santiago Grisolía Chair in Biomedicine (2012)

While Dr. Blasco has undoubtedly mentored emerging scientists through her leadership roles, specific student names are not documented in the provided materials. Her administrative positions as Program Director and Vice-Director indicate substantial grant management expertise, though individual funding details remain unspecified.

As head of the Telomeres and Telomerase Group, she directs a multidisciplinary team employing advanced molecular and cellular techniques to dissect telomere maintenance mechanisms. Her laboratory's work continues to illuminate critical connections between telomere biology, genomic instability, and therapeutic interventions for cancer and aging-related diseases.